GPR55 ligands promote receptor coupling to multiple signalling pathways

British Journal of Pharmacology

Volumn 160, Issue 3, 2010, Pages 604-614

  Henstridge, Christopher M ^a   Balenga, Nariman Ab ^b   Schröder, Ralf ^c   Kargl, Julia K ^b   Platzer, Wolfgang ^b   Martini, Lene ^d   Arthur, Simon ^e   Penman, June ^a   Whistler, Jennifer L ^d   Kostenis, Evi ^c   Waldhoer, Maria ^b   Irving, Andrew J ^a,b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cannabinoid; GPCR; GPR55; LPI

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 55; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSOPHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; RIMONABANT; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; CANNABINOID; GPR55 PROTEIN, HUMAN; LIGAND; LYSOPHOSPHATIDYLINOSITOL; MORPHOLINE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTERNALIZATION; MICROFLUOROMETRY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BIOASSAY; DRUG EFFECTS; METABOLISM; PROCEDURES; TRANSFORMED CELL LINE;

BIOLOGICAL ASSAY; CANNABINOIDS; CELL LINE, TRANSFORMED; ENDOCYTOSIS; HUMANS; LIGANDS; LYSOPHOSPHOLIPIDS; MORPHOLINES; PIPERIDINES; PYRAZOLES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 77952660029     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00625.x     Document Type: Article

References (25)

1. Brown AJ, Robin HC (2009). Chapter 5. Is GPR55 an anandamide receptor? Vitam Horm 81 : 111 137.
2. Coutts AA, Navi-Goffer S, Ross RA, Macewan DJ, Mackie K, Pertwee RG et al. (2001). Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J Neurosci 21 : 2425 2433.
3. Delfino F, Walker WH (1999). Hormonal regulation of the NF-kappaB signalling pathway. Mol Cell Endocrinol 157 : 1 9.
4. Fang Y, Ferrie AM, Fontaine NH, Mauro J, Balakrishnan J (2006). Resonant waveguide grating biosensor for living cell sensing. Biophys J 91 : 1925 1940.
5. Fang Y, Li G, Ferrie AM (2007). Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. J Pharmacol Toxicol Methods 55 : 314 322.
6. Galandrin S, Oligny-Longpre G, Bonin H, Ogawa K, Gales C, Bouvier M (2008). Conformational rearrangements and signalling cascades involved in ligand-biased mitogen-activated protein kinase signalling through the beta1-adrenergic receptor. Mol Pharmacol 74 : 162 172.
7. 2+ signalling and NFAT activation. FASEB J 23 : 183 193.
8. Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA et al. (2007). The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br J Pharmacol 152 : 825 831.
9. Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS et al. (2009). Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem 284 : 29817 29827.
10. Kenakin T (2007). Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 72 : 1393 1401.
11. 1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. AAPS PharmSci 1 : E4.
12. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K (2008). GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 105 : 2699 2704.
13. Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T (2007). Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362 : 928 934.
14. Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (2009). 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. J Biochem 145 : 13 20.
15. Pertwee RG (2005). Pharmacological actions of cannabinoids. Handb Exp Pharmacol 1 51.
16. Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N et al. (2009). Differential changes in GPR55 during microglial cell activation. FEBS Lett 583 : 2071 2076.
17. Ross RA (2009). The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 30 : 156 163.
18. Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J et al. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152 : 1092 1101.
19. Schröder R, Merten N, Mathiesen JM, Martini L, Kruljac-Letunic A, Krop F et al. (2009). The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signalling cascade activation. J Biol Chem 284 : 1324 1336.
20. Shaywitz AJ, Greenberg ME (1999). CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68 : 821 861.
21. Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP et al. (2008). The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139 : 225 236.
22. 2+ signalling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression. J Cell Sci 121 : 1704 1717.
23. Waldhoer M, Kledal TN, Farrell H, Schwartz TW (2002). Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signalling activities. J Virol 76 : 8161 8168.
24. Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, Greasley PJ et al. (2009). The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 106 : 16511 16516.
25. Yin H, Chu A, Li W, Wang B, Shelton F, Otero F et al. (2009). Lipid G-protein-coupled receptor ligand identification using beta-arrestin pathhunter assay. J Biol Chem 284 : 12328 12338.